Variability of macrolide-resistant profile in Mycobacterium avium complex pulmonary disease
Antimicrobial Agents and Chemotherapy · 06.11.2024 · 68 (11)
DOI: 10.1128/aac.01213-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 06.11.2024. Verfasst von Kiyoharu Fukushima und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, National Hospital Organization, Osaka Toneyama Medical Center, Toyonaka, Osaka, Japan. Hauptthemen laut MEDLINE: Mycobacterium avium Complex, Macrolides, Mycobacterium avium-intracellulare Infection, Anti-Bacterial Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED), Foundation of Kinoshita Memorial Enterprise (は), Senri Life Science Foundation.
Abstract (Originalsprache)
This single-center retrospective study aimed to analyze the variability of macrolide resistance (MR) in 68 patients with Mycobacterium avium complex pulmonary disease. Among 25 patients treated without macrolides, 13 (52%) reverted to macrolide-susceptible (MS) profiles. Only one (2%) of 43 patients who continued macrolide treatment showed this change. We compared 30 MR isolates with recent specimens. Among them, seven shifted to MS (five attributed to clonally related strains; two resulting from reinfection or polyclonal infection).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, National Hospital Organization, Osaka Toneyama Medical Center, Toyonaka, Osaka, Japan.
- Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
- Department of Host Defense, Research Institute for Microbial Diseases (RIMD), Osaka University, Suita, Osaka, Japan.
- Laboratory of Host Defense, World Premier Institute Immunology Frontier Research Center (WPI-IFReC), Osaka University, Suita, Osaka, Japan.
- Global Center for Medical Engineering and Informatics, Suita, Osaka, Japan.
- Department of Infection Metagenomics, Genome Information Research Center, Research Institute for Microbial Diseases (RIMD), Osaka University, Suita, Osaka, Japan.
ORCID-Profile: Kiyoharu Fukushima, Yuki Matsumoto, Shota Nakamura, Hiroshi Kida
Förderung
- Japan Agency for Medical Research and Development (AMED)
- Foundation of Kinoshita Memorial Enterprise (は)
- Senri Life Science Foundation
- Japan Intractable Diseases Research Foundation (JIDRF)
- Shionogi (Shionogi & Co. Ltd.)
- GlaxoSmithKline (GSK)
- MEXT | Japan Society for the Promotion of Science (JSPS)
- Takeda Science Foundation (TSF)
Zitieren
APA
Fukushima, K., Matsumoto, Y., Abe, Y., Hashimoto, K., Motooka, D., Kitada, S., Saito, H., Komukai, S., Fukui, E., Niitsu, T., Nabeshima, H., Nagahama, Y., Yamauchi, J., Nitta, T., Nii, T., Matsuki, T., Tsujino, K., Miki, K., Shintani, Y., …, & Kida, H. (2024). Variability of macrolide-resistant profile in Mycobacterium avium complex pulmonary disease. Antimicrobial Agents and Chemotherapy, 68(11). https://doi.org/10.1128/aac.01213-24
Vancouver
Fukushima K, Matsumoto Y, Abe Y, Hashimoto K, Motooka D, Kitada S, et al. Variability of macrolide-resistant profile in Mycobacterium avium complex pulmonary disease. Antimicrobial Agents and Chemotherapy. 2024;68(11). doi:10.1128/aac.01213-24
BibTeX
@article{Fukushima2024,
author = {Fukushima, Kiyoharu and Matsumoto, Yuki and Abe, Yuko and Hashimoto, Kazuki and Motooka, Daisuke and Kitada, Seigo and Saito, Haruko and Komukai, Sho and Fukui, Eriko and Niitsu, Takayuki and Nabeshima, Hiroshi and Nagahama, Yasuharu and Yamauchi, June and Nitta, Tadayoshi and Nii, Takuro and Matsuki, Takanori and Tsujino, Kazuyuki and Miki, Keisuke and Shintani, Yasushi and Kumanogoh, Atsushi and Akira, Shizuo and Nakamura, Shota and Kida, Hiroshi},
title = {Variability of macrolide-resistant profile in Mycobacterium avium complex pulmonary disease},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
volume = {68},
number = {11},
doi = {10.1128/aac.01213-24}
}
EUVIMED